Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Pharmaceutical Composition For Treating And/Or Preventing Cancer
Abstract: In the present invention, by linking dolastatin 10 or a derivative thereof to an antibody or fragment thereof having immunological reactivity with CAPRIN-1 protein having an amino acid sequence shown in any one of the even numbered SEQ ID NOs: 2 to 30 or an amino acid sequence having 80% or more sequence identity with such amino acid sequence, the anti-tumoral effect by such antibody or such fragment thereof is enhanced.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
01 April 2024
Publication Number
45/2024
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
TORAY INDUSTRIES, INC.
1-1, Nihonbashi-Muromachi 2-chome, Chuo-ku, Tokyo
1038666
Inventors
1. OKANO, Fumiyoshi
c/o Basic Research Center, Toray Industries, Inc., 10-1, Tebiro 6-chome, Kamakura-shi, Kanagawa
2488555
2. SAITO, Takanori
c/o Basic Research Center, Toray Industries, Inc., 10-1, Tebiro 6-chome, Kamakura-shi, Kanagawa
2488555
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202417026948-STATEMENT OF UNDERTAKING (FORM 3) [01-04-2024(online)].pdf | 2024-04-01 |
| 3 | 202417026948-Sequence Listing in txt [01-04-2024(online)].txt | 2024-04-01 |
| 4 | 202417026948-Sequence Listing in PDF [01-04-2024(online)].pdf | 2024-04-01 |
| 5 | 202417026948-REQUEST FOR EXAMINATION (FORM-18) [01-04-2024(online)].pdf | 2024-04-01 |
| 6 | 202417026948-PROOF OF RIGHT [01-04-2024(online)].pdf | 2024-04-01 |
| 7 | 202417026948-POWER OF AUTHORITY [01-04-2024(online)].pdf | 2024-04-01 |
| 8 | 202417026948-FORM 18 [01-04-2024(online)].pdf | 2024-04-01 |
| 9 | 202417026948-FORM 1 [01-04-2024(online)].pdf | 2024-04-01 |
| 10 | 202417026948-DECLARATION OF INVENTORSHIP (FORM 5) [01-04-2024(online)].pdf | 2024-04-01 |
| 11 | 202417026948-COMPLETE SPECIFICATION [01-04-2024(online)].pdf | 2024-04-01 |
| 12 | 202417026948-certified copy of translation [01-04-2024(online)].pdf | 2024-04-01 |
| 13 | 202417026948-MARKED COPIES OF AMENDEMENTS [04-04-2024(online)].pdf | 2024-04-04 |
| 14 | 202417026948-FORM 13 [04-04-2024(online)].pdf | 2024-04-04 |
| 15 | 202417026948-AMMENDED DOCUMENTS [04-04-2024(online)].pdf | 2024-04-04 |
| 16 | 202417026948-FORM 3 [18-09-2024(online)].pdf | 2024-09-18 |